{"id":"allylthiourea","rwe":[{"pmid":"41786613","year":"2026","title":"Hypoosmolarity inhibits ammonia oxidation by terrestrial and freshwater Nitrosopumilaceae members.","finding":"","journal":"The ISME journal","studyType":"Clinical Study"},{"pmid":"41657280","year":"2026","title":"A trithiocyanurate-based chelating agent for the stabilisation of lead in municipal solid waste incineration fly ash.","finding":"","journal":"Environmental technology","studyType":"Clinical Study"},{"pmid":"41642704","year":"2026","title":"In Situ Cross-linked Poly(vinylidene Fluoride)/Polyamidoamine Porous Membrane for Selective Recovery of Low-Concentration Pt(IV) with Enhanced Antifouling Properties.","finding":"","journal":"Langmuir : the ACS journal of surfaces and colloids","studyType":"Clinical Study"},{"pmid":"41407048","year":"2026","title":"Nitrogen assimilation may facilitate enhanced nitrogen removal and reservation in algal-bacterial granular sludge.","finding":"","journal":"Bioresource technology","studyType":"Clinical Study"},{"pmid":"41229682","year":"2025","title":"Comparative transcription profiles of Candidatus Accumulibacter and Propionivibrio under phosphate limitation in sequencing batch reactors.","finding":"","journal":"Frontiers in microbiology","studyType":"Clinical Study"}],"_fda":{"id":"2cc890bb-e861-a6b1-e063-6394a90a494d","set_id":"09a60d62-a479-0f02-e063-6294a90a6d39","openfda":{"unii":["706IDJ14B7"],"route":["ORAL"],"spl_id":["2cc890bb-e861-a6b1-e063-6394a90a494d"],"brand_name":["Thiosinaminum"],"spl_set_id":["09a60d62-a479-0f02-e063-6294a90a6d39"],"package_ndc":["71919-819-01"],"product_ndc":["71919-819"],"generic_name":["ALLYLTHIOUREA"],"product_type":["HUMAN OTC DRUG"],"substance_name":["ALLYLTHIOUREA"],"manufacturer_name":["Washington Homeopathic Products"],"is_original_packager":[true]},"purpose":["USES Indicated for Scarring."],"version":"2","warnings":["STOP USE AND ASK DOCTOR If symptoms persist or recur, discontinue use. If pregnant or nursing, consult a licensed practitioner before using this product."],"effective_time":"20250128","active_ingredient":["ACTIVE INGREDIENTS THIOSINAMINUM 30C"],"inactive_ingredient":["INACTIVE INGREDIENTS Sucrose/Lactose"],"indications_and_usage":["INDICATIONS THIOSINAMINUM Scarring"],"dosage_and_administration":["DIRECTIONS (Adults or Children): Dissolve 3 to 5 pellets under tongue 3 times a day or as directed by a licensed practitioner. Take at greater intervals as condition subsides."],"spl_product_data_elements":["Thiosinaminum ALLYLTHIOUREA SUCROSE LACTOSE ALLYLTHIOUREA ALLYLTHIOUREA white"],"keep_out_of_reach_of_children":["KEEP OUT OF REACH OF CHILDREN As with all medications, keep out of reach of children."],"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL Thiosinaminum kit refill 30c"]},"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Oral","category":"route"},{"label":"Active","category":"status"},{"label":"Scarring","category":"indication"},{"label":"Washington Homeopathic Products","category":"company"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"ARTHRALGIA","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"BLOOD BLISTER","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"BLOOD POTASSIUM ABNORMAL","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"CONTUSION","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"DIZZINESS","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"EYE IRRITATION","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"HOT FLUSH","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"INCORRECT ROUTE OF PRODUCT ADMINISTRATION","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"NECK PAIN","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"PRODUCT PACKAGING CONFUSION","source":"FDA FAERS","actionTaken":"1 reports"}]},"trials":[],"aliases":[],"company":"Washington Homeopathic Products","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=ALLYLTHIOUREA","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:18:50.168477+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:18:56.778499+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ALLYLTHIOUREA","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:18:57.093525+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:18:48.884392+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:18:48.884424+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T00:18:58.683971+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1451910/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:18:57.805781+00:00"}},"allNames":"thiosinaminum","offLabel":[],"synonyms":["Thiosinaminum"],"timeline":[],"approvals":[],"brandName":"Thiosinaminum","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Thiosinaminum's exact mechanism of action is not well understood, but it is believed to involve the inhibition of certain enzymes involved in the formation of scar tissue, such as hyaluronidase and collagenase."},"commercial":{},"references":[{"id":1,"url":"https://api.fda.gov/drug/label.json?search=openfda.generic_name:\"ALLYLTHIOUREA\"","fields":["mechanism","indications","adverse_reactions","contraindications","warnings","dosage"],"source":"OpenFDA Label"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=allylthiourea","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-31T10:39:35.168677","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:18:59.963761+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"allylthiourea","indications":{"approved":[{"name":"Scarring","source":"OpenFDA Label","regulator":"FDA","eligibility":"No specific patient eligibility criteria are mentioned for this indication."}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral"},"crossReferences":{"UNII":"706IDJ14B7","SPL_ID":"2cc890bb-e861-a6b1-e063-6394a90a494d","chemblId":"CHEMBL1451910"},"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Washington Homeopathic Products","relationship":"Original Developer"}],"publicationCount":141,"therapeuticAreas":["Dermatology"],"biosimilarFilings":[],"originalDeveloper":"Washington Homeopathic Products","recentPublications":[{"date":"2026 Mar 6","pmid":"41786613","title":"Hypoosmolarity inhibits ammonia oxidation by terrestrial and freshwater Nitrosopumilaceae members.","journal":"The ISME journal"},{"date":"2026 Feb 9","pmid":"41657280","title":"A trithiocyanurate-based chelating agent for the stabilisation of lead in municipal solid waste incineration fly ash.","journal":"Environmental technology"},{"date":"2026 Feb 17","pmid":"41642704","title":"In Situ Cross-linked Poly(vinylidene Fluoride)/Polyamidoamine Porous Membrane for Selective Recovery of Low-Concentration Pt(IV) with Enhanced Antifouling Properties.","journal":"Langmuir : the ACS journal of surfaces and colloids"},{"date":"2026 Mar","pmid":"41407048","title":"Nitrogen assimilation may facilitate enhanced nitrogen removal and reservation in algal-bacterial granular sludge.","journal":"Bioresource technology"},{"date":"2025","pmid":"41229682","title":"Comparative transcription profiles of Candidatus Accumulibacter and Propionivibrio under phosphate limitation in sequencing batch reactors.","journal":"Frontiers in microbiology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Washington Homeopathic Products","companyId":"washington-homeopathic-products","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Thiosinaminum is a small molecule with the synonyms ALILTIOUREA, ALLYLTHIOUREA, ALLYLTHIOUREE, NSC-1915, THIOSINAMINE, and THIOSINAMINUM.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:18:59.963761+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}